UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM 8-K |
Delaware | 001-34666 | 14-1896129 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit | Description |
99.1 | Press Release, dated July 31, 2014. |
Date: July 31, 2014 | MAXLINEAR, INC. | ||
(Registrant) | |||
By: | /s/ Adam C. Spice | ||
Adam C. Spice | |||
Chief Financial Officer | |||
(Principal Financial Officer) | |||
/s/ Justin Scarpulla | |||
Justin Scarpulla | |||
Chief Accounting Officer and Corporate Controller | |||
(Principal Accounting Officer) |
Exhibit No. | Description |
99.1 | Press Release, dated July 31, 2014. |
Three Months Ended | |||||||||||
June 30, 2014 | March 31, 2014 | June 30, 2013 | |||||||||
Net revenue | $ | 35,592 | $ | 32,501 | $ | 29,773 | |||||
Cost of net revenue | 13,346 | 12,448 | 12,477 | ||||||||
Gross profit | 22,246 | 20,053 | 17,296 | ||||||||
Operating expenses: | |||||||||||
Research and development | 13,892 | 13,095 | 12,315 | ||||||||
Selling, general and administrative | 8,688 | 7,761 | 7,768 | ||||||||
Total operating expenses | 22,580 | 20,856 | 20,083 | ||||||||
Loss from operations | (334 | ) | (803 | ) | (2,787 | ) | |||||
Interest income | 60 | 61 | 58 | ||||||||
Other expense, net | (18 | ) | (12 | ) | (44 | ) | |||||
Loss before income taxes | (292 | ) | (754 | ) | (2,773 | ) | |||||
Provision for income taxes | 320 | 108 | 131 | ||||||||
Net loss | $ | (612 | ) | $ | (862 | ) | $ | (2,904 | ) | ||
Net loss per share: | |||||||||||
Basic | $ | (0.02 | ) | $ | (0.02 | ) | $ | (0.09 | ) | ||
Diluted | $ | (0.02 | ) | $ | (0.02 | ) | $ | (0.09 | ) | ||
Shares used to compute net loss per share: | |||||||||||
Basic | 36,093 | 35,369 | 33,748 | ||||||||
Diluted | 36,093 | 35,369 | 33,748 |
Six Months Ended June 30, | |||||||
2014 | 2013 | ||||||
Net revenue | $ | 68,093 | $ | 56,307 | |||
Cost of net revenue | 25,794 | 22,299 | |||||
Gross profit | 42,299 | 34,008 | |||||
Operating expenses: | |||||||
Research and development | 26,987 | 23,826 | |||||
Selling, general and administrative | 16,449 | 15,171 | |||||
Total operating expenses | 43,436 | 38,997 | |||||
Loss from operations | (1,137 | ) | (4,989 | ) | |||
Interest income | 121 | 117 | |||||
Interest expense | — | (4 | ) | ||||
Other expense, net | (30 | ) | (117 | ) | |||
Loss before income taxes | (1,046 | ) | (4,993 | ) | |||
Provision for income taxes | 428 | 211 | |||||
Net loss | $ | (1,474 | ) | $ | (5,204 | ) | |
Net loss per share: | |||||||
Basic | $ | (0.04 | ) | $ | (0.16 | ) | |
Diluted | $ | (0.04 | ) | $ | (0.16 | ) | |
Shares used to compute net loss per share: | |||||||
Basic | 35,733 | 33,287 | |||||
Diluted | 35,733 | 33,287 |
Three Months Ended | |||||||||||
June 30, 2014 | March 31, 2014 | June 30, 2013 | |||||||||
Operating Activities | |||||||||||
Net loss | $ | (612 | ) | $ | (862 | ) | $ | (2,904 | ) | ||
Adjustments to reconcile net loss to cash provided by operating activities: | |||||||||||
Amortization and depreciation | 1,071 | 1,134 | 1,061 | ||||||||
Amortization of investment premiums, net | 200 | 210 | 258 | ||||||||
Stock-based compensation | 3,685 | 3,393 | 3,339 | ||||||||
Deferred income taxes | — | 11 | — | ||||||||
Impairment of long-lived assets | — | — | 1,131 | ||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 690 | (1,320 | ) | 164 | |||||||
Inventory | 1,279 | (1,010 | ) | (693 | ) | ||||||
Prepaid and other assets | (300 | ) | (42 | ) | (447 | ) | |||||
Accounts payable, accrued expenses and other current liabilities | 562 | 590 | 3,749 | ||||||||
Accrued compensation | 170 | 2,039 | (76 | ) | |||||||
Deferred revenue and deferred profit | (551 | ) | 529 | (341 | ) | ||||||
Accrued price protection liability | 1,132 | (637 | ) | 889 | |||||||
Other long-term liabilities | 224 | 56 | 75 | ||||||||
Net cash provided by operating activities | 7,550 | 4,091 | 6,205 | ||||||||
Investing Activities | |||||||||||
Purchases of property and equipment | (3,196 | ) | (1,445 | ) | (1,280 | ) | |||||
Purchases of intangible assets | — | — | (655 | ) | |||||||
Purchases of available-for-sale securities | (11,065 | ) | (18,699 | ) | (14,945 | ) | |||||
Maturities of available-for-sale securities | 10,800 | 18,195 | 18,200 | ||||||||
Net cash provided by (used in) investing activities | (3,461 | ) | (1,949 | ) | 1,320 | ||||||
Financing Activities | |||||||||||
Payments on capital leases | — | — | (1 | ) | |||||||
Net proceeds from issuance of common stock | 1,510 | 49 | 1,090 | ||||||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (2,852 | ) | (136 | ) | (1,075 | ) | |||||
Net cash provided by (used in) financing activities | (1,342 | ) | (87 | ) | 14 | ||||||
Effect of exchange rate changes on cash and cash equivalents | 1 | (5 | ) | 5 | |||||||
Increase in cash and cash equivalents | 2,748 | 2,050 | 7,544 | ||||||||
Cash and cash equivalents at beginning of period | 28,500 | 26,450 | 17,174 | ||||||||
Cash and cash equivalents at end of period | $ | 31,248 | $ | 28,500 | $ | 24,718 |
Six Months Ended June 30, | |||||||
2014 | 2013 | ||||||
Operating Activities | |||||||
Net loss | $ | (1,474 | ) | $ | (5,204 | ) | |
Adjustments to reconcile net loss to cash provided by operating activities: | |||||||
Amortization and depreciation | 2,205 | 2,042 | |||||
Amortization of investment premiums, net | 410 | 481 | |||||
Stock-based compensation | 7,078 | 6,128 | |||||
Deferred income taxes | 11 | — | |||||
Impairment of long-lived assets | — | 1,195 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (630 | ) | (3,297 | ) | |||
Inventory | 269 | 536 | |||||
Prepaid and other assets | (342 | ) | (330 | ) | |||
Accounts payable, accrued expenses and other current liabilities | 1,152 | 36 | |||||
Accrued compensation | 2,209 | 2,201 | |||||
Deferred revenue and deferred profit | (22 | ) | 307 | ||||
Accrued price protection liability | 495 | 2,797 | |||||
Other long-term liabilities | 280 | 114 | |||||
Net cash provided by operating activities | 11,641 | 7,006 | |||||
Investing Activities | |||||||
Purchases of property and equipment | (4,641 | ) | (1,822 | ) | |||
Purchases of intangible assets | — | (655 | ) | ||||
Purchases of available-for-sale securities | (29,764 | ) | (47,117 | ) | |||
Maturities of available-for-sale securities | 28,995 | 45,500 | |||||
Net cash used in investing activities | (5,410 | ) | (4,094 | ) | |||
Financing Activities | |||||||
Payments on capital leases | — | (2 | ) | ||||
Net proceeds from issuance of common stock | 1,559 | 1,113 | |||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (2,988 | ) | (1,123 | ) | |||
Net cash used in financing activities | (1,429 | ) | (12 | ) | |||
Effect of exchange rate changes on cash and cash equivalents | (4 | ) | 8 | ||||
Increase in cash and cash equivalents | 4,798 | 2,908 | |||||
Cash and cash equivalents at beginning of period | 26,450 | 21,810 | |||||
Cash and cash equivalents at end of period | $ | 31,248 | $ | 24,718 |
June 30, 2014 | March 31, 2014 | June 30, 2013 | |||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 31,248 | $ | 28,500 | $ | 24,718 | |||||
Short-term investments, available-for-sale | 43,875 | 44,769 | 37,084 | ||||||||
Accounts receivable, net | 20,688 | 21,378 | 17,855 | ||||||||
Inventory | 9,763 | 11,042 | 9,355 | ||||||||
Prepaid expenses and other current assets | 1,960 | 1,675 | 1,814 | ||||||||
Total current assets | 107,534 | 107,364 | 90,826 | ||||||||
Property and equipment, net | 9,858 | 7,913 | 6,149 | ||||||||
Long-term investments, available-for-sale | 16,385 | 15,428 | 19,453 | ||||||||
Intangible assets | 590 | 670 | 958 | ||||||||
Other long-term assets | 596 | 581 | 267 | ||||||||
Total assets | $ | 134,963 | $ | 131,956 | $ | 117,653 | |||||
Liabilities and stockholders’ equity | |||||||||||
Current liabilities | $ | 37,726 | $ | 41,691 | $ | 30,803 | |||||
Other long-term liabilities | 1,373 | 1,149 | 903 | ||||||||
Total stockholders’ equity | 95,864 | 89,116 | 85,947 | ||||||||
Total liabilities and stockholders’ equity | $ | 134,963 | $ | 131,956 | $ | 117,653 |
Three Months Ended | |||||||||||
June 30, 2014 | March 31, 2014 | June 30, 2013 | |||||||||
GAAP net loss | $ | (612 | ) | $ | (862 | ) | $ | (2,904 | ) | ||
Stock-based compensation: | |||||||||||
Cost of net revenue | 32 | 29 | 26 | ||||||||
Research and development | 2,384 | 2,194 | 2,158 | ||||||||
Selling, general and administrative | 1,269 | 1,170 | 1,155 | ||||||||
Total stock-based compensation | 3,685 | 3,393 | 3,339 | ||||||||
Share-based bonus plan*: | |||||||||||
Cost of net revenue | 13 | 9 | 18 | ||||||||
Research and development | 657 | 491 | 873 | ||||||||
Selling, general and administrative | 564 | 373 | 289 | ||||||||
Total share-based bonus plan | 1,234 | 873 | 1,180 | ||||||||
Impairment of production masks | — | — | 1,098 | ||||||||
IP litigation costs | 668 | 340 | 1,114 | ||||||||
Non-GAAP net income | $ | 4,975 | $ | 3,744 | $ | 3,827 | |||||
Shares used in computing non-GAAP basic net income per share | 36,093 | 35,369 | 33,748 | ||||||||
Shares used in computing GAAP diluted net loss per share | 36,093 | 35,369 | 33,748 | ||||||||
Dilutive common stock equivalents | 2,682 | 2,949 | 1,531 | ||||||||
Shares used in computing non-GAAP diluted net income per share | 38,775 | 38,318 | 35,279 | ||||||||
Non-GAAP basic net income per share | $ | 0.14 | $ | 0.11 | $ | 0.11 | |||||
Non-GAAP diluted net income per share | $ | 0.13 | $ | 0.10 | $ | 0.11 |
* | Share-based bonus plan for the three months ended June 30, 2014 and March 31, 2014 relates to an accrual related to our performance based bonus plan for 2014, which will be settled in stock in 2015. Share-based bonus plan for the three months ended June 30, 2013 relates to an accrual related to our performance based bonus plan for 2013, which was settled in stock in May 2014. |
Six Months Ended June 30, | |||||||
2014 | 2013 | ||||||
GAAP net loss | $ | (1,474 | ) | $ | (5,204 | ) | |
Stock-based compensation: | |||||||
Cost of net revenue | 61 | 50 | |||||
Research and development | 4,578 | 3,912 | |||||
Selling, general and administrative | 2,439 | 2,166 | |||||
Total stock-based compensation | 7,078 | 6,128 | |||||
Share-based bonus plan*: | |||||||
Cost of net revenue | 22 | 29 | |||||
Research and development | 1,148 | 1,517 | |||||
Selling, general and administrative | 937 | 642 | |||||
Total share-based bonus plan | 2,107 | 2,188 | |||||
Impairment of production masks | — | 1,098 | |||||
IP litigation costs | 1,008 | 2,073 | |||||
Non-GAAP net income | $ | 8,719 | $ | 6,283 | |||
Shares used in computing non-GAAP basic net income per share | 35,733 | 33,287 | |||||
Shares used in computing GAAP diluted net loss per share | 35,733 | 33,287 | |||||
Dilutive common stock equivalents | 2,816 | 1,393 | |||||
Shares used in computing non-GAAP diluted net income per share | 38,549 | 34,680 | |||||
Non-GAAP basic net income per share | $ | 0.24 | $ | 0.19 | |||
Non-GAAP diluted net income per share | $ | 0.23 | $ | 0.18 |
* | Share-based bonus plan for the six months ended June 30, 2014 relates to an accrual related to our performance based bonus plan for 2014, which will be settled in stock in 2015. Share-based bonus plan for the six months ended June 30, 2013 relates to an accrual related to our performance based bonus plan for 2013, which was settled in stock in May 2014. |
Three Months Ended | ||||||||
June 30, 2014 | March 31, 2014 | June 30, 2013 | ||||||
GAAP gross profit as a % of revenue | 62.5 | % | 61.7 | % | 58.1 | % | ||
Stock-based compensation: | ||||||||
Cost of net revenue | 0.1 | % | 0.1 | % | 0.1 | % | ||
Share-based bonus plan: | ||||||||
Cost of net revenue | — | % | — | % | — | % | ||
Impairment of production masks | — | % | — | % | 3.7 | % | ||
Non-GAAP gross profit as a % of revenue | 62.6 | % | 61.8 | % | 61.9 | % | ||
GAAP loss from operations as a % of revenue | (0.9 | )% | (2.5 | )% | (9.4 | )% | ||
Stock-based compensation: | ||||||||
Cost of net revenue | 0.1 | % | 0.1 | % | 0.1 | % | ||
Research and development | 6.7 | % | 6.8 | % | 7.2 | % | ||
Selling, general and administrative | 3.6 | % | 3.6 | % | 3.9 | % | ||
Share-based bonus plan: | ||||||||
Cost of net revenue | — | % | — | % | — | % | ||
Research and development | 1.8 | % | 1.5 | % | 2.9 | % | ||
Selling, general and administrative | 1.6 | % | 1.1 | % | 1.0 | % | ||
Impairment of production masks | — | % | — | % | 3.7 | % | ||
IP litigation costs | 1.9 | % | 1.0 | % | 3.7 | % | ||
Non-GAAP income from operations as a % of revenue | 14.8 | % | 11.6 | % | 13.1 | % |
Six Months Ended June 30, | |||||
2014 | 2013 | ||||
GAAP gross profit as a % of revenue | 62.1 | % | 60.4 | % | |
Stock-based compensation: | |||||
Cost of net revenue | 0.1 | % | 0.1 | % | |
Share-based bonus plan: | |||||
Cost of net revenue | — | % | — | % | |
Impairment of production masks | — | % | 2.0 | % | |
Non-GAAP gross profit as a % of revenue | 62.2 | % | 62.5 | % | |
GAAP loss from operations as a % of revenue | (1.7 | )% | (8.9 | )% | |
Stock-based compensation: | |||||
Cost of net revenue | 0.1 | % | 0.1 | % | |
Research and development | 6.7 | % | 6.9 | % | |
Selling, general and administrative | 3.6 | % | 3.8 | % | |
Share-based bonus plan: | |||||
Cost of net revenue | — | % | — | % | |
Research and development | 1.7 | % | 2.7 | % | |
Selling, general and administrative | 1.4 | % | 1.1 | % | |
Impairment of production masks | — | 2.0 | % | ||
IP litigation costs | 1.5 | % | 3.7 | % | |
Non-GAAP income from operations as a % of revenue | 13.3 | % | 11.4 | % |